Erratum: A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study. (Diabetes care (2018) 41(1672-1680)DOI: 10.2337/dc09-19er08)

Robert Ritzel, Stewart B. Harris, Helen Baron, Hermes Florez, Ronan Roussel, Melanie Espinasse, Isabel Muehlen-Bartmer, Nianxian Zhang, Monica Bertolini, Claire Brulle-Wohlhueter, Medha Munshi, Geremia B. Bolli

Research output: Contribution to journalComment/debate

Abstract

In the article cited above, the ClinicalTrials.gov registration number was incorrect in the footnote section. The correct number is NCT02320721. The online version of this article (https://doi.org/10.2337/dc18-0168) has been corrected.

Original languageEnglish (US)
Number of pages1
JournalDiabetes care
Volume42
Issue number8
DOIs
StatePublished - Aug 1 2019

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Erratum: A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study. (Diabetes care (2018) 41(1672-1680)DOI: 10.2337/dc09-19er08)'. Together they form a unique fingerprint.

  • Cite this